US OptionsDetailed Quotes
GLUE241220P17500
- 0.00
- 0.000.00%
15min DelayClose Dec 3 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest17.50Strike Price0.00Turnover271.47%IV-77.48%PremiumDec 20, 2024Expiry Date7.64Intrinsic Value100Multiplier17DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.7563Delta0.0550Gamma1.20Leverage Ratio-0.0522Theta-0.0059Rho-0.90Eff Leverage0.0066Vega
Monte Rosa Therapeutics Stock Discussion
Monte Rosa Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Versant Venture Capital VI, L.P.(6.6%),Versant Ventures VI GP, L.P.(6.6%), etc.
Monte Rosa Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Versant Venture Capital VI, L.P.
No comment yet